Brief: Thermogenesis Enters Into Supply Agreement With Covid-19 Antibody Test Manufacturer
Aug 13 (Reuters) - Thermogenesis Holdings Inc THMO.O :
* THERMOGENESIS HOLDINGS ENTERS INTO SUPPLY AGREEMENT WITH
NEW EUA
APPROVED COVID-19 ANTIBODY TEST MANUFACTURER; MARKETING TO BEGIN
ON AUGUST 17, 2020
* THERMOGENESIS- ENTERED SUPPLY AGREEMENT WITH BIOHIT
HEALTHCARE
CO., LTD. TO MARKET UNDER THERMOGENESIS BRAND, ITS SARS-COV-2
IGM/IGG ANTIBODY TEST KIT
* THERMOGENESIS HOLDINGS INC - NEW THERMOGENESIS BRANDED
SARS-COV-2 IGM/IGG ANTIBODY TEST KIT IS EXPECTED TO INITIATE
MARKETING ON AUG 17
Source text for Eikon: ID:nPnvLQT7a
Further company coverage: THMO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Thermogenesis Holdings
See all newsThermogenesis Holdings Inc expected to post earnings of 1 cent a share - Earnings Preview
Thermogenesis Holdings Inc reports results for the quarter ended in December - Earnings Summary
Thermogenesis Holdings Inc expected to post a loss of 1 cent a share - Earnings Preview
Thermogenesis Holdings Inc expected to post a loss of 1 cent a share - Earnings Preview
Brief: Thermogenesis Holdings Says On Jan 8 Co Received Nasdaq Letter Notifying It No Longer Complies With Minimum Bid Price Requirement For Listing On Nasdaq